Institute Technology Management Unit (ITMU) is designated/established to act as Secretariat for the Institute Technology Management Committee (ITMC) of ICAR-NIFMD. ITMC is the highest body which takes important decisions for the intellectual property management at ICAR-NIFMD and is chaired by the Director, ICAR-NIFMD. Institute Technology Management Unit (ITMU) at ICAR-NIFMD is the unit act for IP related matters/progress/concerns viz., filing of patents, approval of the technology for commercialization, pricing of the technologies ready for commercialization etc.
1. Proper implementation of ICAR guidelines for IP management and technology transfer/ commercialization.
2. Increase awareness and enhancing literacy for IPR and capacity building.
3. Recognition of inventors/innovators who need to be suitably rewarded for their ingenuity.
4. Existing technology improvement for production of newer/cheaper/better products.
5. New technology evaluation and screening.
6. Overcome barriers to commercialization.
7. Progression towards effective technology transfer from lab - to – industry.
8. Foster entrepreneurship and empower small and medium enterprises with IP asset accumulation, management and use.
9. Need to strengthen the technological capacity to get the best benefit.
| S.No | Name of Scientist | Designation | Role |
|---|---|---|---|
| 01 | Dr Rabindra Prasad Singh | Director | Chairman |
| 02 | Dr S K Singh | PS & Joint Director (Research), ICAR-IVRI | External Member |
| 03 | Dr Jajati K. Mohapatra | Principal Scientist |
Member |
| 04 | Dr S. Saravanan | Principal Scientist, I/C, PME | Member |
| 05 | Dr Shyam Singh Dahiya | Scientist (SS) | Member |
| 06 | Dr Jitendra K. Biswal | Senior Scientist |
Member Secretary
(From 15/07/2021 to till date) |
| S.No | Title | Application No. | Date of Filing | Name of the Inventors |
|---|---|---|---|---|
| 01 | Thermotolerant foot-and-mouth disease virus (FMDV) serotype O Indian vaccine strain O IND R2/1975 with enhanced immunogenicity in Cattle | 202111037282 | 17th August 2021 | Dr Biswal J.K., Dr Mohapatra J.K., Dr Subramaniam S., Dr Ranjan R., Dr Pattnaik B., Dr Sreenivasa B.P., Dr Sanyal A., Dr Basagoudanavar S.H., Dr Hosamani M., and Dr TamilSelvan R.P. |
| 02 | Live-attenuated FMDV serotype O IND R2/1975 Negative-Marker Vaccine Srain | 202211067069 | 22nd November 2022 | Dr Biswal J.K., Dr Mohapatra J.K., Dr Subramaniam S., Dr Ranjan R., Dr Singh R.P. |
| 03 | Monoclonal antibody - based competitive ELISA for the detection of antibodies to Foot and Mouth Disease Virus (FMDV) non-structural protein as a marker of infection | 202311089799 | 29th December 2023 | Mallick S., Singh R.P., Mohapatra J.K., Biswal J.K., Rout M, Ranjan R. |